Actinium Pharmaceuticals, Inc. [ATNM] has reported $81,000.0 in revenue for year ended Dec 31, 2023.
Also Read:
The company said in a filing before the Securities and Exchange Commission that its loss for the year was $48.8 million.
Based in New York, New York, Actinium Pharmaceuticals, Inc. operates in the Manufacturing sector.